Aug 10, 2026

Keel Infrastructure (KEEL) Stock Gains Despite Q2 Revenue Shortfall Amid HPC Tra...

Keel Infrastructure (KEEL) stock up 1.57% after Q2 earnings miss. Revenue dropped 50% YoY to $30.4M amid HPC pivot. Company mainta...

Aug 10, 2026

Tenax Therapeutics (TENX) Shares Collapse 84% on Failed Phase 3 Trial Results

Tenax Therapeutics (TENX) shares plummeted 84% after Phase 3 LEVEL trial failed primary and secondary endpoints for TNX-103 in PH-...

Aug 10, 2026

monday.com (MNDY) Stock Surges Over 6% Following Strong Q2 Earnings Report

monday.com (MNDY) stock surged 6.35% after reporting Q2 EPS of $1.48, beating estimates. AI ARR doubled as revenue reached $364.6M...

Aug 10, 2026

Intel (INTC) Stock Dips 3% Following $15 Billion Equity Offering Announcement

Intel (INTC) shares dropped 3% after announcing a $15 billion stock offering to fund its foundry expansion and meet surging AI chi...

Aug 10, 2026

Barrick Gold (GOLD) Shares Tumble 6% Despite Revenue Beat on Soaring Production...

Barrick Gold (GOLD) fell 6% after Q2 earnings disappointed on rising costs. The miner also announced a $1.95B Newmont settlement o...

Aug 10, 2026

Micron (MU) Stock Rises Despite Apple’s Tests with Chinese Memory Chip Maker

Micron (MU) stock rises 1.4% premarket as Apple tests Chinese memory chips. Citi cuts target to $1,150, while analyst sees potenti...

Aug 10, 2026

Corning (GLW) Stock Gains Ground as Apple Shelves Premium Glass iPhone Design

Corning (GLW) stock rose 0.63% to $166.72 despite Apple canceling its all-glass iPhone. Q2 earnings surpassed estimates with reven...

Aug 10, 2026

Meta (META) Stock: Zuckerberg Unveils Muse Glimmer, Pushes for AI Policy Changes

Meta (META) stock climbed as Zuckerberg unveiled Muse Glimmer AI and urged the U.S. to remove open-source restrictions to compete...

Aug 10, 2026

Applied Materials (AMAT) Earnings Preview: Q3 Results Due Thursday, August 13

Applied Materials (AMAT) releases Q3 fiscal 2026 earnings on Aug 13. Analysts project $3.39 EPS, ~$9B revenue. Stock down 27% from...

Aug 10, 2026

AbCellera (ABCL) Stock Surges 32% on Positive Menopause Treatment Results

AbCellera (ABCL) stock soared 32% after its menopause treatment ABCL635 achieved Phase 2 trial goals, reducing hot flashes without...